5.00
-0.03 (-0.60%)
| Previous Close | 5.03 |
| Open | 4.95 |
| Volume | 1,628,131 |
| Avg. Volume (3M) | 1,902,871 |
| Market Cap | 512,912,480 |
| Price / Sales | 0.880 |
| Price / Book | 0.760 |
| 52 Weeks Range |
| Profit Margin | -15.96% |
| Operating Margin (TTM) | -9.49% |
| Diluted EPS (TTM) | -0.700 |
| Quarterly Revenue Growth (YOY) | 10.30% |
| Total Debt/Equity (MRQ) | 2,020.06% |
| Current Ratio (MRQ) | 1.79 |
| Operating Cash Flow (TTM) | -15.64 M |
| Levered Free Cash Flow (TTM) | 5.58 M |
| Return on Assets (TTM) | -17.66% |
| Return on Equity (TTM) | -277.62% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Bullish | |
| Stock | The Oncology Institute, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 2.00 |
|
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 9.22% |
| % Held by Institutions | 34.63% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |